Effects of Treatment on Decision-making in Major Depression

PHASE4CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Major Depressive DisorderHealthy Controls
Interventions
DRUG

Any FDA Approved Antidepressant

Any FDA-approved antidepressant prescribed within standard dose range to treat Major Depressive Disorder will be taken for 6 weeks. Psychiatric follow-up will be performed during the study participation. At the end of the study, these participants will receive assistance in transitioning their care to another provider, depending on their individual circumstances.

Trial Locations (1)

30322

Emory Mood and Anxiety Disorders Program, Atlanta

All Listed Sponsors
lead

Emory University

OTHER

NCT01916824 - Effects of Treatment on Decision-making in Major Depression | Biotech Hunter | Biotech Hunter